Biotronik SE & Co. KG: Coronary Artery Disease trials

The registry lists 41 Coronary Artery Disease studies with Biotronik SE & Co. KG as lead sponsor. 1 are open to participants now and 5 have results posted.

Phase 1 1Phase 2 2Phase 3 1Phase 4 1No phase 38(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Resorbable Magnesium Scaffolds RegistryRecruitingNCT04679740
• Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery LesionsCompletedNCT04175626Results posted
• BIOTRONIK Orsiro Pre-Marketing RegistrationCompletedNCT02870985Not applicableResults posted
• Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery LesionsCompletedNCT02389946Not applicableResults posted
• BIOHELIX-I Bare Metal Stent StudyCompletedNCT01612767Phase 2/3Results posted
• MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy StudyCompletedNCT01531725Not applicableResults posted
• Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo LesionsActive, not recruitingNCT07091682Not applicable
• Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold SystemActive, not recruitingNCT05540223Not applicable
• BIOFLOW-VIII All-comers Orsiro Mission Safety and Performance RegistryActive, not recruitingNCT04555174
• First in Men Study: BIOMAG-IActive, not recruitingNCT04157153Not applicable
• Bioflow-DAPT StudyCompletedNCT04137510Phase 4
• BIOFLOW-SV Portugal RegistryTerminatedNCT03600961
• BIOFLOW-SV All Comers RegistryTerminatedNCT03600948
• Vascular Implant Safety and Efficacy StudyCompletedNCT03263858Not applicable
• Safety and Clinical Performance of a Sirolimus-eluting Absorbable Metal ScaffoldSuspendedNCT02916485Not applicable
• BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IVActive, not recruitingNCT02817802
• Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III)CompletedNCT02716220Not applicable
• BIOTRONIK - BIOFLOW-III Registry French SatelliteStatus unknownNCT02273648
• BIOFLOW-III UK Satellite Registry Orsiro Stent SystemStatus unknownNCT02257710
• BIOFLOW-III VIP Russia Registry Orsiro Stent SystemStatus unknownNCT02247492
• BIOFLOW III Satellite-ELADIS Orsiro Stent SystemCompletedNCT02029092
• BIOFLOW III Satellite-Italy Orsiro Stent SystemCompletedNCT02028728
• First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II)Status unknownNCT01960504Not applicable
• BIOFLOW III Asia Registry Orsiro Stent SystemCompletedNCT01941290
• Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting StentStatus unknownNCT01939249Not applicable
• PaneLux PTCA : Proposing an Alternative Treatment to patiEnts for Whom DES Implantation is Not Indicated, Thanks to Pantera LUX Drug Eluting BalloonStatus unknownNCT01930903Not applicable
• BIOFLOW-III Israel Satellite RegistryCompletedNCT01895712
• BIOFLOW-III Hungary Satellite RegistryTerminatedNCT01892917
• BIOFLOW-III Canada Satellite RegistryCompletedNCT01880242
• BIOFLOW-III Belgium Satellite RegistryCompletedNCT01831336
• The Treatment of Coronary Artery Lesions Using the PRO-Kinetic Energy Cobalt-Chromium, Bare-Metal StentTerminatedNCT01811927Not applicable
• BIOFLOW-III Austria Satellite RegistryCompletedNCT01667016
• BIOFLOW-III Sweden Satellite RegistryCompletedNCT01667003
• Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.CompletedNCT01651390Not applicable
• BIOFLOW-III Romania Satellite RegistryTerminatedNCT01593059
• BIOFLOW-III All-comers Orsiro Safety and Performance RegistryStatus unknownNCT01553526
• BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery LesionsCompletedNCT01426139Not applicable
• Study of the Orsiro Drug Eluting Stent SystemStatus unknownNCT01356888Not applicable
• First in Man Experience With a Drug Eluting Stent in De Novo Coronary Artery LesionsCompletedNCT01214148Phase 1/2
• Genotyping Infarct Patients to Adjust and Normalize Thienopyridine TreatmentCompletedNCT01134380
• Drug Eluting Pantera Lux Catheter RegistryCompletedNCT01081366